In the promptly evolving field of oncology investigate, precise and economical mutation screening is important for establishing qualified therapies. The KRAS providers Platform plays a pivotal purpose Within this landscape by featuring detailed methods for KRAS mutation profiling and analysis. KRAS mutations, found in about 95% of RAS-connected onc